×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Lacrimal Duct Stent Tube Market

ID: MRFR/HC/40120-HCR
200 Pages
Rahul Gotadki
October 2025

Lacrimal Duct Stent Tube Market Research Report: Size, Share, Trend Analysis By Types (Silicone Stents, Polyethylene Stents, Hydrogel Stents), By End Use (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics), By Material (Silicone, Polyethylene, Metal), By Applications (Chronic Epiphora Treatment, Post-Surgical Management, Trauma Management) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Lacrimal Duct Stent Tube Market Infographic
×
Lacrimal Duct Stent Tube Market Infographic Full View
Purchase Options

Lacrimal Duct Stent Tube Market Summary

As per Market Research Future analysis, the Lacrimal Duct Stent Tube Market Size was estimated at 0.5677 USD Billion in 2024. The Lacrimal Duct Stent Tube industry is projected to grow from 0.608 USD Billion in 2025 to 1.208 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.11% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Lacrimal Duct Stent Tube Market is experiencing robust growth driven by technological advancements and increasing awareness of eye health.

  • North America remains the largest market for lacrimal duct stent tubes, reflecting a strong demand for advanced eye care solutions.
  • The Asia-Pacific region is emerging as the fastest-growing market, likely due to expanding healthcare infrastructure and rising disposable incomes.
  • Silicone stents dominate the market, while hydrogel stents are gaining traction as the fastest-growing segment due to their biocompatibility.
  • Technological advancements and the aging population are key drivers, alongside an increase in surgical procedures and interventions.

Market Size & Forecast

2024 Market Size 0.5677 (USD Billion)
2035 Market Size 1.208 (USD Billion)
CAGR (2025 - 2035) 7.11%

Major Players

Abbott Laboratories (US), Bausch Health Companies Inc. (CA), Carl Zeiss AG (DE), Eagle Vision Inc. (US), EyeGate Pharmaceuticals Inc. (US), Hoya Corporation (JP), Medtronic plc (IE), Santen Pharmaceutical Co. Ltd. (JP), SurgiQuest Inc. (US)

Lacrimal Duct Stent Tube Market Trends

The Lacrimal Duct Stent Tube Market is currently experiencing notable developments driven by advancements in medical technology and increasing awareness regarding eye health. The demand for effective solutions to treat lacrimal duct obstructions is rising, as healthcare providers seek to enhance patient outcomes. Innovations in stent materials and designs are likely to improve the comfort and efficacy of these devices, potentially leading to broader adoption in clinical settings. Furthermore, the growing prevalence of eye-related disorders may contribute to a sustained interest in this market segment, as practitioners aim to address the needs of patients more effectively. In addition, the Lacrimal Duct Stent Tube Market appears to be influenced by the expansion of healthcare infrastructure in various regions. As more facilities become equipped to perform specialized eye procedures, the accessibility of lacrimal duct stenting is expected to improve. This trend may encourage further research and development, fostering a competitive landscape among manufacturers. Overall, the market seems poised for growth, with ongoing innovations and an increasing focus on patient-centered care shaping its future trajectory.

Technological Advancements

Recent innovations in materials and design for lacrimal duct stent tubes are enhancing their performance and patient comfort. Manufacturers are exploring biocompatible materials that reduce irritation and improve the longevity of stents, which may lead to better clinical outcomes.

Rising Awareness of Eye Health

There is a growing emphasis on eye health and the importance of addressing lacrimal duct obstructions. Increased public awareness campaigns and educational initiatives by healthcare professionals are likely to drive demand for effective treatment options in the Lacrimal Duct Stent Tube Market.

Expansion of Healthcare Facilities

The ongoing development of healthcare infrastructure, particularly in emerging markets, is facilitating access to specialized eye care. As more facilities adopt advanced technologies for lacrimal duct procedures, the market for stent tubes is expected to expand significantly.

Lacrimal Duct Stent Tube Market Drivers

Rising Awareness of Eye Health

The Lacrimal Duct Stent Tube Market is significantly influenced by the rising awareness of eye health among the population. As individuals become more informed about the importance of ocular health, there is a corresponding increase in the diagnosis and treatment of eye-related conditions. This heightened awareness is leading to more patients seeking medical advice for issues such as chronic tearing and dry eye syndrome, which often necessitate the use of lacrimal duct stents. Market data suggests that the demand for these stents is expected to rise as healthcare providers emphasize preventive care and early intervention. Consequently, this trend is likely to bolster the growth of the lacrimal duct stent tube market.

Expansion of Healthcare Facilities

The expansion of healthcare facilities is a critical driver for the Lacrimal Duct Stent Tube Market. As more hospitals and specialized eye care centers emerge, the accessibility of ophthalmic services is improving. This expansion is particularly evident in developing regions, where investments in healthcare infrastructure are on the rise. Enhanced access to eye care services is likely to lead to an increase in the number of procedures involving lacrimal duct stents. Market analysis indicates that the proliferation of healthcare facilities could result in a substantial uptick in the utilization of these stents, thereby positively impacting the overall market growth.

Aging Population and Associated Eye Conditions

The aging population is a significant factor influencing the Lacrimal Duct Stent Tube Market. As individuals age, they become more susceptible to various eye conditions, including those that affect the lacrimal system. Conditions such as dacryostenosis and chronic epiphora are more prevalent among older adults, leading to an increased demand for lacrimal duct stents. Data indicates that the demographic shift towards an older population is expected to drive market growth, as healthcare systems adapt to meet the needs of this demographic. Consequently, the lacrimal duct stent tube market is likely to see a surge in demand as more elderly patients seek treatment for their eye-related issues.

Increased Surgical Procedures and Interventions

The Lacrimal Duct Stent Tube Market is also being propelled by an increase in surgical procedures and interventions related to eye care. As surgical techniques become more refined and less invasive, the number of procedures involving lacrimal duct stents is on the rise. This trend is supported by data showing a steady increase in ophthalmic surgeries, which often require the use of stents to ensure proper drainage and function. The growing acceptance of these procedures among both patients and healthcare providers is likely to further stimulate demand for lacrimal duct stents, contributing to the overall expansion of the market.

Technological Advancements in Lacrimal Duct Stent Tube Market

The Lacrimal Duct Stent Tube Market is experiencing a notable transformation due to rapid technological advancements. Innovations in materials and design are enhancing the efficacy and comfort of stents. For instance, the introduction of biocompatible materials is reducing the risk of complications, thereby increasing patient satisfaction. Furthermore, advancements in minimally invasive surgical techniques are facilitating easier implantation and removal of stents. According to recent data, the market for lacrimal duct stents is projected to grow at a compound annual growth rate of approximately 6% over the next few years. This growth is indicative of the increasing reliance on advanced technologies in ophthalmic procedures, which is likely to drive the demand for lacrimal duct stents.

Market Segment Insights

By Type: Silicone Stents (Largest) vs. Hydrogel Stents (Fastest-Growing)

In the Lacrimal Duct Stent Tube Market, the segment distribution reveals that Silicone Stents hold the largest market share due to their robust performance and customer preference for long-term implantation. Polyethylene Stents, while significant, have a smaller share as they are used in specific clinical scenarios. Hydrogel Stents, on the other hand, are emerging rapidly in the market, thanks to their biocompatibility and patient comfort, indicating a shift towards innovative materials in medical devices.

Silicone Stents (Dominant) vs. Hydrogel Stents (Emerging)

Silicone Stents are currently the dominant force in the Lacrimal Duct Stent Tube Market, valued for their durability and versatility in various ophthalmologic procedures. They are extensively used due to their proven track record and ease of implantation. In contrast, Hydrogel Stents are categorized as an emerging segment, driven by advancements in materials technology that enhance patient comfort and reduce inflammatory responses. Their unique hydrophilic properties allow improved biocompatibility, positioning them as a preferred choice in an increasing number of surgeries. As healthcare professionals continue to seek better outcomes and patient experiences, the demand for Hydrogel Stents is expected to grow significantly in the coming years.

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Lacrimal Duct Stent Tube Market, hospitals command the largest share, benefiting from their comprehensive services and advanced surgical capabilities. They provide a broad range of ophthalmic procedures, thus seeing increased utilization of lacrimal duct stents. Ambulatory surgical centers, while smaller in share, have been rapidly increasing as they offer cost-effective solutions with quicker patient turnover and reduced waiting times, making them an appealing choice for outpatient procedures. Ophthalmology clinics also play a significant role, mainly focusing on outpatient services, but they do not match the extensive capabilities of hospitals. Their market share is stable as they accommodate a dedicated patient base.

Ophthalmology Clinics: Stalwart vs. Ambulatory Surgical Centers: Fast-Growing

In the context of the Lacrimal Duct Stent Tube Market, ophthalmology clinics serve as stalwarts by providing specialized and focused services that cater to patients with ocular issues. Their established presence allows them to effectively maintain a steady patient flow and ensure ongoing demand for stent placement procedures. Conversely, ambulatory surgical centers are experiencing rapid growth due to their efficiency and the trend towards outpatient care. These centers are equipped to handle a variety of procedures and are appealing for their lower costs and convenience, attracting more patients who prefer same-day surgical services. This shift reflects changes in patient preferences, driving their popularity in the market.

By Material: Silicone (Largest) vs. Polyethylene (Fastest-Growing)

In the Lacrimal Duct Stent Tube Market, the material composition plays a significant role in the selection and application of products. Currently, silicone holds the largest market share due to its biocompatibility and flexibility, making it a preferred choice among healthcare providers. Polyethylene, while having a smaller share, is experiencing rapid growth as its affordability and ease of manufacturing are driving its adoption. The metal segment remains a specialty choice, appealing to a niche audience attracted by its durability.

Silicone (Dominant) vs. Polyethylene (Emerging)

Silicone stents are considered the dominant material in the lacrimal duct stent market due to their excellent biocompatibility, flexible design, and proven efficacy in clinical settings. This material has established a strong reputation among surgeons, promoting its widespread use in various ophthalmic procedures. On the other hand, polyethylene stents are emerging as a cost-effective alternative, gaining traction for their manufacturing ease and lower pricing. While they may not yet match silicone's dominance, their advantages are contributing to an increasing market presence and appeal among budget-conscious healthcare providers looking for effective solutions.

By Application: Chronic Epiphora Treatment (Largest) vs. Post-Surgical Management (Fastest-Growing)

The lacrimal duct stent tube market demonstrates a significant distribution of applications, where Chronic Epiphora Treatment stands out as the largest segment. This segment addresses a crucial need for patients suffering from excessive tearing, which drives substantial demand among healthcare providers. In comparison, Post-Surgical Management is emerging rapidly due to an increase in surgical interventions related to ocular health, making it an essential component of recovery protocols. This sector's growth is facilitated by advancements in surgical techniques and increased awareness of post-operative care among patients and clinicians alike.

Chronic Epiphora Treatment (Dominant) vs. Post-Surgical Management (Emerging)

Chronic Epiphora Treatment remains the dominant application in the lacrimal duct stent tube market, primarily catering to patients with excessive lacrimal secretion issues. This segment is characterized by its established protocols and strong support from clinical evidence. On the other hand, Post-Surgical Management is an emerging segment, increasingly recognized for its importance in enhancing recovery and patient outcomes following ocular surgeries. The growth of this segment is fueled by a growing number of procedures and a heightened focus on minimizing complications during recovery, making it a crucial area for future innovation and development.

Get more detailed insights about Lacrimal Duct Stent Tube Market

Key Companies in the Lacrimal Duct Stent Tube Market include

Industry Developments

  • Q2 2024: Kaneka Corporation Receives FDA Approval for New Lacriflow™ Bicanalicular Nasolacrimal Duct Stent Kaneka Corporation announced that its Lacriflow™ bicanalicular nasolacrimal duct stent received FDA 510(k) clearance, allowing for expanded use in minimally invasive tear duct procedures in the United States.
  • Q1 2024: FCI S.A.S. Launches New Self-Retaining Bicanalicular Intubation Set for Lacrimal Duct Procedures FCI S.A.S., a leading ophthalmic device manufacturer, introduced a new self-retaining bicanalicular intubation set designed to simplify lacrimal duct stenting and reduce procedure time for oculoplastic surgeons.
  • Q3 2024: BVI Medical Announces Strategic Partnership with Santen Pharmaceutical for Distribution of Lacrimal Stent Products in Asia BVI Medical entered into a distribution agreement with Santen Pharmaceutical to expand the reach of its lacrimal duct stent tubes and related products across key Asian markets.
  • Q2 2025: Cook Medical Opens New Manufacturing Facility for Lacrimal Stent Tubes in Ireland Cook Medical inaugurated a new facility in Limerick, Ireland, dedicated to the production of lacrimal duct stent tubes, aiming to meet growing demand in Europe and North America.
  • Q1 2025: Teleflex Incorporated Acquires Lacrimal Stent Portfolio from Innovia Medical Teleflex Incorporated completed the acquisition of Innovia Medical’s lacrimal stent product line, strengthening its position in the ophthalmic surgical device market.
  • Q4 2024: FCI S.A.S. Appoints Dr. Marie Dupont as Chief Medical Officer FCI S.A.S. announced the appointment of Dr. Marie Dupont as Chief Medical Officer to lead clinical strategy and product development for its lacrimal duct stent tube portfolio.
  • Q2 2024: Eagle Labs Receives CE Mark for Next-Generation Lacrimal Intubation Set Eagle Labs, a surgical device manufacturer, received CE Mark approval for its next-generation lacrimal intubation set, enabling commercialization in the European Union.
  • Q3 2025: BVI Medical Secures $30 Million Series C Funding to Expand Lacrimal Stent Tube Production BVI Medical raised $30 million in Series C funding to scale up manufacturing capacity for its lacrimal duct stent tubes and accelerate global market expansion.

Future Outlook

Lacrimal Duct Stent Tube Market Future Outlook

The Lacrimal Duct Stent Tube Market is projected to grow at a 7.11% CAGR from 2024 to 2035, driven by increasing demand for minimally invasive procedures and advancements in medical technology.

New opportunities lie in:

  • Development of biodegradable stent materials for enhanced patient comfort.
  • Expansion into emerging markets with tailored product offerings.
  • Integration of telemedicine for remote monitoring of stent performance.

By 2035, the Lacrimal Duct Stent Tube Market is expected to achieve substantial growth and innovation.

Market Segmentation

Lacrimal Duct Stent Tube Market Type Outlook

  • Silicone Stents
  • Polyethylene Stents
  • Hydrogel Stents

Lacrimal Duct Stent Tube Market End Use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmology Clinics

Lacrimal Duct Stent Tube Market Material Outlook

  • Silicone
  • Polyethylene
  • Metal

Lacrimal Duct Stent Tube Market Application Outlook

  • Chronic Epiphora Treatment
  • Post-Surgical Management
  • Trauma Management

Report Scope

MARKET SIZE 2024 0.5677(USD Billion)
MARKET SIZE 2025 0.608(USD Billion)
MARKET SIZE 2035 1.208(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.11% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Abbott Laboratories (US), Bausch Health Companies Inc. (CA), Carl Zeiss AG (DE), Eagle Vision Inc. (US), EyeGate Pharmaceuticals Inc. (US), Hoya Corporation (JP), Medtronic plc (IE), Santen Pharmaceutical Co. Ltd. (JP), SurgiQuest Inc. (US)
Segments Covered Types, End Use, Material, Applications, Regional
Key Market Opportunities Advancements in biocompatible materials enhance patient comfort in the Lacrimal Duct Stent Tube Market.
Key Market Dynamics Rising demand for minimally invasive procedures drives innovation and competition in the lacrimal duct stent tube market.
Countries Covered North America, Europe, APAC, South America, MEA
Leave a Comment

FAQs

What is the projected market valuation of the Lacrimal Duct Stent Tube Market by 2035?

The Lacrimal Duct Stent Tube Market is projected to reach a valuation of 1.208 USD Billion by 2035.

What was the market valuation of the Lacrimal Duct Stent Tube Market in 2024?

In 2024, the market valuation of the Lacrimal Duct Stent Tube Market was 0.5677 USD Billion.

What is the expected CAGR for the Lacrimal Duct Stent Tube Market during the forecast period 2025 - 2035?

The expected CAGR for the Lacrimal Duct Stent Tube Market during the forecast period 2025 - 2035 is 7.11%.

Which companies are considered key players in the Lacrimal Duct Stent Tube Market?

Key players in the Lacrimal Duct Stent Tube Market include Abbott Laboratories, Bausch Health Companies Inc., and Medtronic plc.

What are the main types of lacrimal duct stents available in the market?

The main types of lacrimal duct stents available include Silicone Stents, Polyethylene Stents, and Hydrogel Stents.

How did the valuation of Silicone Stents change from 2024 to 2035?

The valuation of Silicone Stents is expected to increase from 0.2271 USD Billion in 2024 to 0.4872 USD Billion by 2035.

What end-use segments are driving the Lacrimal Duct Stent Tube Market?

The end-use segments driving the market include Hospitals, Ambulatory Surgical Centers, and Ophthalmology Clinics.

What applications are associated with the use of lacrimal duct stents?

Applications associated with lacrimal duct stents include Chronic Epiphora Treatment, Post-Surgical Management, and Trauma Management.

What is the projected valuation for Polyethylene Stents by 2035?

The projected valuation for Polyethylene Stents is expected to rise from 0.1135 USD Billion in 2024 to 0.2436 USD Billion by 2035.

How does the market for Hydrogel Stents compare to other types in 2025?

In 2025, the market for Hydrogel Stents is anticipated to be on par with Silicone Stents, both valued at approximately 0.4872 USD Billion.

What is the estimated market size of the Global Lacrimal Duct Stent Tube Market in 2024?

The Global Lacrimal Duct Stent Tube Market is expected to be valued at 0.7 USD Billion in 2024.

What is the projected market size of the Global Lacrimal Duct Stent Tube Market by 2035?

The market is projected to be valued at 1.2 USD Billion by 2035.

Which region is anticipated to dominate the Global Lacrimal Duct Stent Tube Market in 2024?

North America is anticipated to dominate the market with a valuation of 0.35 USD Billion in 2024.

How much is the European market for Lacrimal Duct Stent Tubes expected to be valued at in 2035?

The European market for Lacrimal Duct Stent Tubes is expected to be valued at 0.3 USD Billion in 2035.

What are the expected market values for different material types of Lacrimal Duct Stent Tubes in 2024?

In 2024, the market values for material types are 0.25 USD Billion for Silicone, 0.2 USD Billion for Polymer, and 0.15 USD Billion for Metal.

What is the projected market growth rate for the APAC region from 2024 to 2035?

The APAC region is projected to grow from a market value of 0.1 USD Billion in 2024 to 0.25 USD Billion in 2035.

What challenges and growth drivers are impacting the Global Lacrimal Duct Stent Tube Market?

The market faces growth drivers such as increasing patient awareness and challenges related to product availability.

What is the expected market value for South America in 2035?

The expected market value for South America in 2035 is projected to be 0.1 USD Billion.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions